Carbapenemase Transmission in Enterobacter cloacae

Carbapenem-resistant Enterobacter cloacae is an important healthcare-associated pathogen because resistance can arise through both bacterial lineage expansion and movement of carbapenemase-encoding genes between strains. The reference study, published in BMC Microbiology in 2025, examines these processes together rather than treating resistance as a single phenotype. Its central contribution is a combined analysis of gene location, antimicrobial susceptibility, conjugative transfer, mobile genetic elements, and strain relatedness.

Study Background and Research Question

Carbapenemase-encoding genes are particularly consequential in Enterobacterales because they can compromise carbapenems and frequently travel on plasmids carrying additional resistance determinants. The authors focused on carbapenem-resistant E. cloacae collected from eight teaching hospitals in Guangdong Province, China, during December 2022 to June 2024. According to the reference study, the work was motivated by concern that increased antibiotic exposure, disrupted healthcare services, and complex infections associated with the COVID-19 era could alter resistance transmission patterns.

The research question was therefore broader than whether isolates carried a carbapenemase gene. The investigators asked which carbapenemase genes were present, whether they were located on plasmids or chromosomes, how readily they could transfer to a recipient strain, which mobile elements surrounded them, and whether apparently unrelated clinical isolates belonged to shared genotypes. This design is relevant to the study of antibiotic resistance mechanisms because it links molecular context with observable susceptibility and epidemiology.

Key Innovation from the Reference Study

The study’s innovation lies in integrating several levels of evidence from the same collection of isolates. PCR established the presence of carbapenemase-encoding genes, while variable-temperature sodium dodecyl sulfate plasmid elimination helped distinguish plasmid-associated from chromosomal carriage. Conjugation experiments then tested whether the resistance determinants were transferable rather than merely detectable. Finally, mobile-element profiling and ERIC-PCR provided complementary information about genetic mobility and clonal relationships.

This layered strategy separates two transmission routes that are often conflated. Horizontal dissemination is supported when a resistance determinant transfers between bacterial cells, whereas vertical or clonal dissemination is suggested when closely related strains occur in multiple clinical locations. The reference study found evidence for both processes. That conclusion is more informative than a prevalence estimate alone because infection-control responses may differ depending on whether transmission is driven primarily by a successful clone, a mobile plasmid, or both.

Methods and Experimental Design Insights

The investigators analyzed 54 carbapenem-resistant E. cloacae isolates from the participating hospitals. Initial molecular screening used PCR for carbapenemase-encoding genes. Variable-temperature SDS plasmid elimination was used as a practical approach to infer whether detected genes were plasmid-borne, chromosomal, or present in both locations. Because plasmid curing can be incomplete and may affect bacterial fitness, the resulting localization assignments are best interpreted alongside PCR and transfer data rather than as an independent proof of complete genomic structure.

Antimicrobial susceptibility was assessed by broth microdilution. This allowed the authors to compare the CEG-positive and CEG-negative groups across imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. Conjugation assays used a recipient strain to evaluate transferability, followed by PCR confirmation of carbapenemase genes in transconjugants. The study also screened six mobile genetic elements, including ISEcp1, and used ERIC-PCR with NTSYS software to classify strain relatedness.

Protocol Parameters

• Isolate selection: Use confirmed carbapenem-resistant E. cloacae isolates from multiple clinical departments and institutions when the aim is to distinguish local outbreaks from broader dissemination, following the multi-hospital design of the reference study.
• Gene detection: Combine carbapenemase-targeted PCR with a method that assesses plasmid association; PCR positivity alone does not establish genomic location.
• Susceptibility testing: Apply broth microdilution with standardized inoculum, quality controls, and independently interpreted breakpoints. Compare gene-positive and gene-negative isolates without assuming that every resistance phenotype is caused by the detected carbapenemase.
• Transfer assessment: Confirm putative transconjugants by PCR and include appropriate donor, recipient, and selection controls. A successful transfer assay demonstrates laboratory mobility, not necessarily transmission frequency in patients.
• Relatedness analysis: Use ERIC-PCR or a higher-resolution genomic method to assess clustering, and interpret shared profiles together with hospital, department, specimen, and collection metadata.

Core Findings and Why They Matter

Carbapenemase-encoding genes were detected in 46 of 54 isolates, corresponding to 85.19%, according to the reported results. The dominant pattern involved bla_NDM-1. Eighteen isolates, or 33.33%, carried bla_NDM-1 on both chromosomes and plasmids, while 25 isolates, or 46.30%, carried the gene exclusively on plasmids. Two isolates carried only a plasmid-associated bla_IMP, and one carried plasmid-associated bla_NDM-1 together with bla_KPC-2. The combination of plasmid and chromosomal carriage suggests that resistance may persist through stable genomic integration while remaining capable of mobilization through plasmid-associated copies.

The CEG-positive group showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with statistical significance reported at P<0.05. This result supports the clinical importance of carbapenemase carriage as part of a broader multidrug-resistant phenotype. It does not mean that every listed phenotype is mechanistically attributable to the carbapenemase itself; porin changes, efflux, aminoglycoside-modifying enzymes, and other resistance determinants may contribute.

Transfer experiments showed that carbapenemase-encoding genes transferred in 44 of 46 testable isolates, a 95.65% success rate. The transfer success was 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2. These denominators are important: the results indicate strong laboratory transferability for the tested NDM and IMP determinants, but they do not establish equal mobility for all gene types.

ISEcp1 was the most prevalent of the six surveyed mobile genetic elements, detected in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile-element types simultaneously were the most common configuration, representing 22 of 54 isolates, or 40.74%. Such co-occurrence provides a plausible genetic context for resistance accumulation, although the study does not prove that every detected element directly mobilized a specific carbapenemase gene.

ERIC-PCR divided the 54 isolates into 17 genotypes. Types E and G were each found in 11 isolates, or 20.37%, and originated from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. Together with the conjugation data, these findings support a dual transmission model: clonal spread across healthcare settings and horizontal movement of mobile resistance determinants.

The epidemiological distribution was also uneven. The highest detection frequencies occurred among male patients, elderly patients, respiratory-medicine patients, and sputum specimens, at 35 of 54, 39 of 54, 11 of 54, and 18 of 54, respectively. These are descriptive distributions rather than proof of independent risk factors. They nevertheless identify populations and specimen pathways that may be useful for surveillance prioritization.

Comparison with Existing Internal Articles

The internal article Gentamycin Sulfate in Resistance and Ribosome Function Analysis provides a mechanistic complement to this paper by discussing aminoglycoside exposure, bacterial protein synthesis research, and ribosome function analysis. The Guangdong study contributes the epidemiological observation that CEG-positive isolates had higher gentamicin resistance; it does not directly analyze 30S ribosomal binding, mistranslation, or aminoglycoside-modifying enzymes.

Similarly, Gentamycin Sulfate in Multidrug Resistance: New Practical Insights is relevant to the paper’s conjugation and horizontal-transfer theme. Its workflow perspective can help frame laboratory controls, but it should be treated as contextual material rather than evidence that replaces the reference study’s isolate-level results.

Why this cross-domain matters, maturity, and limitations

Connecting hospital surveillance with bacterial protein synthesis research is useful because phenotype, gene mobility, and antibiotic target biology describe different layers of the same resistance problem. The evidence is mature enough to support careful susceptibility and transfer assays, but it is not sufficient to infer a ribosome-level mechanism from the Guangdong dataset alone. Researchers should therefore use aminoglycoside experiments to test specific hypotheses rather than to reinterpret the paper’s gene-transfer findings as direct evidence of altered ribosome function.

Limitations and Transferability

The study has several constraints. It sampled teaching hospitals within one province and used a relatively limited isolate collection, so prevalence estimates may not generalize to other regions, hospital types, or community settings. The observational design also cannot determine whether pandemic-era antibiotic use caused the detected resistance patterns. Associations with sex, age, department, or specimen type may reflect referral patterns, underlying illness, sampling intensity, or local infection-control practices.

Plasmid elimination and PCR provide valuable screening information but do not offer the resolution of complete plasmid and chromosome sequencing. ERIC-PCR is useful for identifying relatedness clusters, yet it has lower discriminatory power than whole-genome comparison and may not distinguish recent transmission from shared background lineages. Conjugation success under laboratory conditions likewise does not quantify transfer in patients or the hospital environment. Future work should therefore validate gene location, mobile-element structure, and strain relationships with higher-resolution genomic approaches while retaining phenotypic susceptibility and epidemiological metadata.

Despite these limitations, the study is transferable as a framework. A robust surveillance program should pair carbapenemase detection with localization, susceptibility testing, transferability assessment, mobile-element analysis, and strain relatedness. This prevents an incomplete interpretation in which a positive PCR result is mistaken for a full explanation of transmission.

Research Support Resources

Researchers can use Gentamycin Sulfate (SKU A2514) to support controlled aminoglycoside exposure, bacterial protein synthesis research, and ribosome function analysis in related laboratory workflows. The product is a research reagent, not a treatment recommendation, and the reference study did not evaluate it as an intervention; concentrations, controls, and resistance endpoints should therefore be selected according to the specific experimental system.